Neurological manifestations of COVID-19 in pregnancy: a cross-sectional study.

The occurrence of neurological manifestations and complications in pregnant women compared to non-pregnant women with COVID-19 is unclear. This cross-sectional study included women aged over 18 years hospitalized with SARS-CoV-2 infection confirmed by RT-PCR from March to June 2020 in Recife, Brazil. We evaluated 360 women, including 82 pregnant patients who were significantly younger (27.

Pregnancy and neurologic complications of COVID-19: A scoping review.

While neurologic complications are frequently reported among patients with COVID-19 in the general population, they are unknown in pregnant women. This paper summarizes the case reports of pregnant women with confirmed SARS-CoV-2 infection plus a specified neurologic diagnosis. Until November 2021, 18 case reports were found.

Neurological manifestations as prognostic factors in COVID-19: a retrospective cohort study.

Background: Neurological manifestations are frequent during COVID-19 but have been poorly studied as prognostic markers of COVID-19.

Objectives: The aim of this study was to assess whether neurological manifestations are associated with a poor prognosis of COVID-19, and which patient and COVID-19 characteristics were associated with encephalopathy.

Methods: This was a retrospective cohort study and included patients admitted with COVID-19 in four hospitals from Recife, Brazil.

Headache, anosmia, ageusia and other neurological symptoms in COVID-19: a cross-sectional study.

Background: Neurological symptoms are frequent among patients with COVID-19. Little is known regarding the repercussions of neurological symptoms for patients and how these symptoms are related to one another.

Objectives: To determine whether there is an association between the neurological symptoms in patients with COVID-19, and to characterize the headache.

Headache associated with COVID-19: Frequency, characteristics and association with anosmia and ageusia.

Objectives: To assess the frequency and characteristics of headache in patients with COVID-19 and whether there is an association between headache and anosmia and ageusia.

Methods: This was a cross-sectional study. Consecutive patients admitted to hospital with COVID-19, confirmed by reverse transcription polymerase chain reaction (RT-PCR) technique, were assessed by neurologists.

Migraine and Markers of Carotid Atherosclerosis in Middle-Aged Women: A Cross-Sectional Study.

Objective: This study evaluated the association between migraine and the markers of carotid artery disease.

Background: Migraine increases the risk of cardiovascular events, but its relationship with vascular dysfunction is unclear.

Methods: In this cross-sectional study, middle-aged women with no known cardiovascular diseases underwent clinical, neurological, and laboratory evaluations; pulse wave velocity (PWV) assessment; and carotid artery ultrasonography.

Migraine and cerebrovascular diseases: Epidemiology, pathophysiological, and clinical considerations.

Migraine and cerebrovascular diseases are disabling disorders, which are possibly closely interrelated. Heterogeneous and scattered evidence in literature remains a challenge. We searched for systematic reviews including diverse cerebrovascular events in migraineurs and reported relevant original studies to update the evidence when necessary.

[Hypothyroid polyneuropathy in a patient with autoimmune polyglandular syndrome type 2: case report].

The incidence of polyneuropathy in patients with hypothyroidism is not precisely known, but some studies report that about 25% to 42% of patients may show neuropathic clinical signs. We report a case of autoimmune poliglandular syndrome type 2 (APS-2), whose initial presentation was hypothyroid polyneuropathy. A 41-year-old man complained of slowly progressive paresthesias and weakness affecting all four limbs, and associated with frequent drowsiness, weakness, cold intolerance, dizziness, nausea, and craving for salt.